secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0001104659-24-098228
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers closes MedisourceRx acquisition; registers 976K shares for resale
-----------------------------------------------------------------------------

- Acquisition of Seaview Enterprises LLC (MedisourceRx) closed on September 5, 2024.
- 976,341 shares of Class A common stock issued to Nivagen Pharmaceuticals as part of consideration.
- Prospectus supplement filed on September 9, 2024 to register resale of those shares.
- Purchase agreement was originally entered on July 5, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000110465924098228/0001104659-24-098228-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000110465924098228/tm2422489d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-098228

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer